<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37311918</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>The differential panorama of clinical features of lupus erythematosus patients with different onset ages: a cross-sectional multicenter study from China.</ArticleTitle><Pagination><StartPage>2353</StartPage><EndPage>2367</EndPage><MedlinePgn>2353-2367</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06661-1</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aims to compare the differences among patients of different onset ages in various subtypes of lupus erythematosus (LE) and to draw a panorama of the clinical characteristics of patients with different onset ages.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Subjects were recruited from the Lupus Erythematosus Multicenter Case-control Study in Chinese populations (LEMCSC), grouped by the age of onset (childhood-onset: onset&#x2009;&lt;&#x2009;18&#xa0;years, adult-onset: onset 18-50&#xa0;years, late-onset: onset&#x2009;&gt;&#x2009;50&#xa0;years). The data collected included demographic characteristics, LE-related systemic involvement, LE-related mucocutaneous manifestations, and laboratory results. All included patients were assigned into three groups: systemic LE (SLE) group (with systemic involvement, with or without mucocutaneous lesions), cutaneous LE (CLE) group (patients who were accompanied by any type of LE-specific cutaneous manifestations), and isolated cutaneous LE (iCLE) group (patients who were in CLE group without systemic involvements). Data were analyzed using R version 4.0.3.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2097 patients were involved, including 1865 with SLE and 232 with iCLE. We also identified 1648 patients with CLE among them, as there was some overlap between the SLE population and CLE population (patients with SLE and LE-specific cutaneous manifestations). Later-onset lupus patients seemed to be less female predominance (p&#x2009;&lt;&#x2009;0.001) and have less systemic involvement (except arthritis), lower positive rates of autoimmune antibodies, less ACLE, and more DLE. Moreover, childhood-onset SLE patients presented a higher risk of LE family history (p&#x2009;=&#x2009;0.002, vs adult-onset SLE). In contrast to other LE-nonspecific manifestations, the self-reported photosensitivity history decreased with the age of onset in SLE patients (51.8%, 43.4%, and 39.1%, respectively) but increased in iCLE patients (42.4%, 64.9%, and 89.2%, respectively). There was also a gradual increase in self-reported photosensitivity from SLE, CLE, to iCLE in both adult-onset and late-onset lupus patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A negative correlation was suggested between the age of onset and the likelihood of systemic involvement, except for arthritis. As the age of onset increases, patients have a greater propensity to exhibit DLE compared to ACLE. Moreover, the presence of rapid response photodermatitis (i.e., self-reported photosensitivity) was associated with a lower rate of systemic involvement.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">This study was registered with the Chinese Clinical Trial Registry (registration number: ChiCTR2100048939) on July 19, 2021, retrospectively registered. Key Points &#x2022; We confirmed some phenomena that have been found in patients with SLE, such as the highest proportion of females of reproductive age, the higher risk of LE family history in childhood-onset SLE patients, and the less self-reported photosensitivity in the late-onset SLE group. We also compared the similarities and differences of these phenomena in patients with CLE or iCLE for the first time. &#x2022; In patients with SLE, the proportion of females peaked in adult-onset patients, but this phenomenon disappeared in iCLE patients: the female-male ratio tends to decrease from childhood-onset iCLE, adult-onset iCLE, to late-onset iCLE. &#x2022; Patients with early-onset lupus are more likely to have acute cutaneous lupus erythematosus (ACLE), and patients with late-onset lupus are more likely to have discoid lupus erythematosus (DLE). &#x2022; In contrast to other LE-nonspecific manifestations, the incidence of rapid response photodermatitis (i.e., self-reported photosensitivity) decreased with the age of onset in SLE patients but increased with the age of onset in iCLE patients.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yu</LastName><ForeName>Yangyiyi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jin</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research On Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Shihang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research On Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Haijing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Hai</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Siqi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ruifang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Heng</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Jieyue</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Shuangyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Yixin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fen</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Guanghui</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Qianjin</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-7749-9618</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, Changsha, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Basic and Translational Research On Immune-Mediated Skin Diseases, Chinese Academy of Medical Sciences, Nanjing, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, China. qianlu5860@pumcderm.cams.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No.81830097</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>No.2021-I2M-1-059</GrantID><Agency>Chinese Academy of Medical Sciences Initiative for Innovative Medicine</Agency><Country/></Grant><Grant><GrantID>2020-RC320-003</GrantID><Agency>Special Funds for the Basic Research and Development Program in the Central Non-profit Research Institutesof China</Agency><Country/></Grant><Grant><GrantID>32141004</GrantID><Agency>Special Program of National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>81874253</GrantID><Agency>Innovative Research Group Project of the National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2022T150742</GrantID><Agency>Ontario Ministry of Health and Long-Term Care</Agency><Country/></Grant><Grant><GrantID>2020RC2014</GrantID><Agency>Program for Top 100 Innovative Talents in Colleges and Universities of Hebei Province</Agency><Country/></Grant><Grant><GrantID>2021JJ40837</GrantID><Agency>Natural Science Foundation of Hunan Province China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008178" MajorTopicYN="Y">Lupus Erythematosus, Cutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008179" MajorTopicYN="Y">Lupus Erythematosus, Discoid</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010787" MajorTopicYN="Y">Photosensitivity Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001168" MajorTopicYN="Y">Arthritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Connective tissue disease</Keyword><Keyword MajorTopicYN="N">Cross-sectional study</Keyword><Keyword MajorTopicYN="N">Lupus</Keyword><Keyword MajorTopicYN="N">Lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>13</Day><Hour>23</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37311918</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06661-1</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06661-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Justiz Vaillant AA, Goyal A, Varacallo M (2023) Systemic lupus erythematosus.&#xa0;In: StatPearls [Internet].&#xa0;StatPearls Publishing, Treasure Island (FL)</Citation></Reference><Reference><Citation>Wenzel J (2019) Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies. Nat Rev Rheumatol 15(9):519&#x2013;532</Citation><ArticleIdList><ArticleId IdType="pubmed">31399711</ArticleId><ArticleId IdType="doi">10.1038/s41584-019-0272-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineles D, Valente A, Warren B, Peterson MG, Lehman TJ, Moorthy LN (2011) Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus 20(11):1187&#x2013;1192</Citation><ArticleIdList><ArticleId IdType="pubmed">21768176</ArticleId><ArticleId IdType="doi">10.1177/0961203311412096</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraki LT, Feldman CH, Liu J, Alarcon GS, Fischer MA, Winkelmayer WC et al (2012) Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum 64(8):2669&#x2013;2676</Citation><ArticleIdList><ArticleId IdType="pubmed">22847366</ArticleId><ArticleId IdType="pmc">3564552</ArticleId><ArticleId IdType="doi">10.1002/art.34472</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees F, Doherty M, Grainge M, Davenport G, Lanyon P, Zhang W (2016) The incidence and prevalence of systemic lupus erythematosus in the UK, 1999&#x2013;2012. Ann Rheum Dis 75(1):136&#x2013;141</Citation><ArticleIdList><ArticleId IdType="pubmed">25265938</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2014-206334</ArticleId></ArticleIdList></Reference><Reference><Citation>Font J, Pallares L, Cervera R, Lopez-Soto A, Navarro M, Bosch X et al (1991) Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 50(10):702&#x2013;705</Citation><ArticleIdList><ArticleId IdType="pubmed">1958093</ArticleId><ArticleId IdType="pmc">1004535</ArticleId><ArticleId IdType="doi">10.1136/ard.50.10.702</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto H, Tsuda H, Hirano T, Takasaki Y, Matsumoto T, Hirose S (1987) Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol 14(3):497&#x2013;501</Citation><ArticleIdList><ArticleId IdType="pubmed">3625631</ArticleId></ArticleIdList></Reference><Reference><Citation>Antolin J, Amerigo MJ, Cantabrana A, Roces A, Jimenez P (1995) Systemic lupus erythematosus: clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE. Clin Rheumatol 14(6):678&#x2013;685</Citation><ArticleIdList><ArticleId IdType="pubmed">8608688</ArticleId><ArticleId IdType="doi">10.1007/BF02207936</ArticleId></ArticleIdList></Reference><Reference><Citation>Domenech I, Aydintug O, Cervera R, Khamashta M, Jedryka-Goral A, Vianna JL et al (1992) Systemic lupus erythematosus in 50 year olds. Postgrad Med J 68(800):440&#x2013;444</Citation><ArticleIdList><ArticleId IdType="pubmed">1437923</ArticleId><ArticleId IdType="pmc">2399336</ArticleId><ArticleId IdType="doi">10.1136/pgmj.68.800.440</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM et al (1998) A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 17(6):468&#x2013;77</Citation><ArticleIdList><ArticleId IdType="pubmed">9890674</ArticleId><ArticleId IdType="doi">10.1007/BF01451282</ArticleId></ArticleIdList></Reference><Reference><Citation>Massias JS, Smith EMD, Al-Abadi E, Armon K, Bailey K, Ciurtin C et al (2020) Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. Lupus 29(5):474&#x2013;481</Citation><ArticleIdList><ArticleId IdType="pubmed">32233733</ArticleId><ArticleId IdType="pmc">7528537</ArticleId><ArticleId IdType="doi">10.1177/0961203320909156</ArticleId></ArticleIdList></Reference><Reference><Citation>Cann MP, Sage AM, McKinnon E, Lee SJ, Tunbridge D, Larkins NG et al (2022) Childhood systemic lupus erythematosus: presentation, management and long-term outcomes in an Australian cohort. Lupus 31(2):246&#x2013;255</Citation><ArticleIdList><ArticleId IdType="pubmed">35037500</ArticleId><ArticleId IdType="doi">10.1177/09612033211069765</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh AP, Nag F, Biswas S, Rao R, De A (2020) Clinicopathological and immunological profile of patients with cutaneous manifestations and their relationship with organ involvement in systemic lupus erythematosus attending a tertiary care center of Eastern India. Indian J Dermatol 65(1):22&#x2013;28</Citation><ArticleIdList><ArticleId IdType="pubmed">32029935</ArticleId><ArticleId IdType="pmc">6986128</ArticleId><ArticleId IdType="doi">10.4103/ijd.IJD_282_19</ArticleId></ArticleIdList></Reference><Reference><Citation>De Oliveira NT, Gomes Silva N, Dos Santos TAFG, Nisihara R, Skare TL (2020) Clinical and autoantibody profile in male and female patients with systemic lupus erythematosus: a retrospective study in 603 Brazilian patients. Eur J Rheumatol 7(4):164&#x2013;168. https://doi.org/10.5152/eurjrheum.2020.20023</Citation></Reference><Reference><Citation>Ribero S, Sciascia S, Borradori L, Lipsker D (2017) The cutaneous spectrum of lupus erythematosus. Clin Rev Allergy Immunol 53(3):291&#x2013;305</Citation><ArticleIdList><ArticleId IdType="pubmed">28752372</ArticleId><ArticleId IdType="doi">10.1007/s12016-017-8627-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Fetter T, Braegelmann C, de Vos L, Wenzel J (2022) Current concepts on pathogenic mechanisms and histopathology in cutaneous lupus erythematosus. Front Med (Lausanne) 9:915828</Citation><ArticleIdList><ArticleId IdType="pubmed">35712102</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.915828</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677&#x2013;2686</Citation><ArticleIdList><ArticleId IdType="pubmed">22553077</ArticleId><ArticleId IdType="pmc">3409311</ArticleId><ArticleId IdType="doi">10.1002/art.34473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn A, Kuehn E, Meuth AM, Haust M, Nyberg F, Werth V et al (2009) Development of a core set questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun Rev 8(8):702&#x2013;712</Citation><ArticleIdList><ArticleId IdType="pubmed">19232553</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2009.02.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H, Huang T, Wu R, Zhao M, Wu H, Long H et al (2020) A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum. Lupus 29(14):1854&#x2013;1865</Citation><ArticleIdList><ArticleId IdType="pubmed">33028176</ArticleId><ArticleId IdType="doi">10.1177/0961203320959716</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H, Zhou S, Yu Y, Zhao M, Wu H, Long H, Fu S, Wu R, Yin H, Liao J, Luo S, Liu Y, Zhang Q, Zhang P, Tan Y,&#xa0;Luo S, Huang X, Li F, Ling G, Lu Q&#xa0;(2023) Panoramic view of clinical features of lupus erythematosus: a cross-sectional multicentre study from China. Lupus Sci Med 10(1):e000819. https://doi.org/10.1136/lupus-2022-000819</Citation></Reference><Reference><Citation>Hedrich CM, Smith EMD, Beresford MW (2017) Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options. Best Pract Res Clin Rheumatol 31(4):488&#x2013;504</Citation><ArticleIdList><ArticleId IdType="pubmed">29773269</ArticleId><ArticleId IdType="doi">10.1016/j.berh.2018.02.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EMD, Lythgoe H, Hedrich CM (2019) Vasculitis in juvenile-onset systemic lupus erythematosus. Front Pediatr 7:149</Citation><ArticleIdList><ArticleId IdType="pubmed">31143758</ArticleId><ArticleId IdType="pmc">6521594</ArticleId><ArticleId IdType="doi">10.3389/fped.2019.00149</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM (2019) Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. Clin Immunol 209:108274</Citation><ArticleIdList><ArticleId IdType="pubmed">31678365</ArticleId><ArticleId IdType="doi">10.1016/j.clim.2019.108274</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnaud L, Mathian A, Boddaert J, Amoura Z (2012) Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment. Drugs Aging 29(3):181&#x2013;189</Citation><ArticleIdList><ArticleId IdType="pubmed">22263748</ArticleId><ArticleId IdType="doi">10.2165/11598550-000000000-00000</ArticleId></ArticleIdList></Reference><Reference><Citation>Riveros Frutos A, Holgado S, Sanvisens Berge A, Casas I, Olive A, Lopez-Longo FJ et al (2021) Late-onset versus early-onset systemic lupus: characteristics and outcome in a national multicentre register (RELESSER). Rheumatology (Oxford) 60(4):1793&#x2013;1803</Citation><ArticleIdList><ArticleId IdType="pubmed">33106841</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/keaa477</ArticleId></ArticleIdList></Reference><Reference><Citation>Catoggio LJ, Soriano ER, Imamura PM, Wojdyla D, Jacobelli S, Massardo L et al (2015) Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup? Lupus 24(8):788&#x2013;795</Citation><ArticleIdList><ArticleId IdType="pubmed">25504653</ArticleId><ArticleId IdType="doi">10.1177/0961203314563134</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng JB, Ni JD, Yao X, Pan HF, Li XP, Xu JH et al (2010) Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus: 1,790 cases. Rheumatol Int 30(8):1017&#x2013;1023</Citation><ArticleIdList><ArticleId IdType="pubmed">19701756</ArticleId><ArticleId IdType="doi">10.1007/s00296-009-1087-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso MD, Martinez-Vazquez F, de Teran TD, Miranda-Filloy JA, Dierssen T, Blanco R et al (2012) Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review. Lupus 21(10):1135&#x2013;1148</Citation><ArticleIdList><ArticleId IdType="pubmed">22652632</ArticleId><ArticleId IdType="doi">10.1177/0961203312450087</ArticleId></ArticleIdList></Reference><Reference><Citation>Aljohani R, Gladman DD, Su J, Urowitz MB (2017) Disease evolution in late-onset and early-onset systemic lupus erythematosus. Lupus 26(11):1190&#x2013;1196</Citation><ArticleIdList><ArticleId IdType="pubmed">28420066</ArticleId><ArticleId IdType="doi">10.1177/0961203317696593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalim H, Pratama MZ, Mahardini E, Winoto ES, Krisna PA, Handono K (2020) Accelerated immune aging was correlated with lupus-associated brain fog in reproductive-age systemic lupus erythematosus patients. Int J Rheum Dis 23(5):620&#x2013;626</Citation><ArticleIdList><ArticleId IdType="pubmed">32107852</ArticleId><ArticleId IdType="doi">10.1111/1756-185X.13816</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A (2018) Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14(10):576&#x2013;590</Citation><ArticleIdList><ArticleId IdType="pubmed">30046148</ArticleId><ArticleId IdType="doi">10.1038/s41574-018-0059-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevenini E, Monti D, Franceschi C (2013) Inflamm-ageing. Curr Opin Clin Nutr Metab Care 16(1):14&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pubmed">23132168</ArticleId><ArticleId IdType="doi">10.1097/MCO.0b013e32835ada13</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T, Larbi A, Dupuis G, Le Page A, Frost EH, Cohen AA et al (2017) Immunosenescence and inflammaging as two sides of the same coin: friends or foes? Front Immunol 8:1960</Citation><ArticleIdList><ArticleId IdType="pubmed">29375577</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2017.01960</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaar M, Eller MS, Gilchrest BA (2002) Fifty years of skin aging. J Investig Dermatol Symp Proc 7(1):51&#x2013;58</Citation><ArticleIdList><ArticleId IdType="pubmed">12518793</ArticleId><ArticleId IdType="doi">10.1046/j.1523-1747.2002.19636.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy G, Isenberg D (2013) Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology (Oxford) 52(12):2108&#x2013;2115</Citation><ArticleIdList><ArticleId IdType="pubmed">23641038</ArticleId><ArticleId IdType="doi">10.1093/rheumatology/ket160</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR (2018) Sex hormones in acquired immunity and autoimmune disease. Front Immunol 9:2279</Citation><ArticleIdList><ArticleId IdType="pubmed">30337927</ArticleId><ArticleId IdType="pmc">6180207</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2018.02279</ArticleId></ArticleIdList></Reference><Reference><Citation>Li WG, Ye ZZ, Yin ZH, Zhang K (2017) Clinical and immunological characteristics in 552 systemic lupus erythematosus patients in a southern province of China. Int J Rheum Dis 20(1):68&#x2013;75</Citation><ArticleIdList><ArticleId IdType="pubmed">25865002</ArticleId><ArticleId IdType="doi">10.1111/1756-185X.12480</ArticleId></ArticleIdList></Reference><Reference><Citation>Borba EF, Araujo DB, Bonfa E, Shinjo SK (2013) Clinical and immunological features of 888 Brazilian systemic lupus patients from a monocentric cohort: comparison with other populations. Lupus 22(7):744&#x2013;749</Citation><ArticleIdList><ArticleId IdType="pubmed">23687065</ArticleId><ArticleId IdType="doi">10.1177/0961203313490432</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek YS, Park SH, Baek J, Roh JY, Kim HJ (2020) Cutaneous lupus erythematosus and its association with systemic lupus erythematosus: a nationwide population-based cohort study in Korea. J Dermatol 47(2):163&#x2013;165</Citation><ArticleIdList><ArticleId IdType="pubmed">31773752</ArticleId><ArticleId IdType="doi">10.1111/1346-8138.15162</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrett P, Thornley S, Scragg R (2016) Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand. Lupus 25(13):1497&#x2013;1502</Citation><ArticleIdList><ArticleId IdType="pubmed">27235700</ArticleId><ArticleId IdType="doi">10.1177/0961203316651745</ArticleId></ArticleIdList></Reference><Reference><Citation>Durosaro O, Davis MD, Reed KB, Rohlinger AL (2009) Incidence of cutaneous lupus erythematosus, 1965&#x2013;2005: a population-based study. Arch Dermatol 145(3):249&#x2013;253</Citation><ArticleIdList><ArticleId IdType="pubmed">19289752</ArticleId><ArticleId IdType="pmc">3953616</ArticleId><ArticleId IdType="doi">10.1001/archdermatol.2009.21</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarukitsopa S, Hoganson DD, Crowson CS, Sokumbi O, Davis MD, Michet CJ Jr et al (2015) Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. Arthritis Care Res (Hoboken) 67(6):817&#x2013;828</Citation><ArticleIdList><ArticleId IdType="pubmed">25369985</ArticleId><ArticleId IdType="doi">10.1002/acr.22502</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SC, Chan EWL, Tang SP (2020) Clinical features, disease activity and outcomes of Malaysian children with paediatric systemic lupus erythematosus: a cohort from a tertiary centre. Lupus 29(9):1106&#x2013;1114</Citation><ArticleIdList><ArticleId IdType="pubmed">32631203</ArticleId><ArticleId IdType="doi">10.1177/0961203320939185</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker LB, Uribe AG, Fernandez M, Vila LM, McGwin G, Apte M et al (2008) Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17(4):314&#x2013;322</Citation><ArticleIdList><ArticleId IdType="pubmed">18413413</ArticleId><ArticleId IdType="pmc">2818044</ArticleId><ArticleId IdType="doi">10.1177/0961203307087875</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney KC, Ferguson TS, Stewart HD, Myers AA, De Ceulaer K (2017) Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis. Lupus 26(13):1448&#x2013;1456</Citation><ArticleIdList><ArticleId IdType="pubmed">28480787</ArticleId><ArticleId IdType="doi">10.1177/0961203317707828</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L et al (2009) Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum 61(1):13&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pubmed">19116979</ArticleId><ArticleId IdType="pmc">2875186</ArticleId><ArticleId IdType="doi">10.1002/art.24091</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina R, Brunner HI (2010) Pediatric lupus&#x2013;are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? Rheum Dis Clin N Am 36(1):53&#x2013;80, vii&#x2212;viii</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2009.12.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrente-Segarra V, Salman Monte TC, Rua-Figueroa I, Sanchez-Alonso F, Lopez-Longo FJ, Galindo-Izquierdo M et al (2017) Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Clin Exp Rheumatol 35(6):1047&#x2013;1055</Citation><ArticleIdList><ArticleId IdType="pubmed">28628467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho CT, Mok CC, Lau CS, Wong RW (1998) Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 57(7):437&#x2013;440</Citation><ArticleIdList><ArticleId IdType="pubmed">9797573</ArticleId><ArticleId IdType="pmc">1752656</ArticleId><ArticleId IdType="doi">10.1136/ard.57.7.437</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu SJ, Luo SF, Wu YJ, Cheng HS, Ho HH (2000) The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 9(2):96&#x2013;100</Citation><ArticleIdList><ArticleId IdType="pubmed">10787005</ArticleId><ArticleId IdType="doi">10.1191/096120300678828109</ArticleId></ArticleIdList></Reference><Reference><Citation>Medlin JL, Hansen KE, Fitz SR, Bartels CM (2016) A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus. Semin Arthritis Rheum 45(6):691&#x2013;697</Citation><ArticleIdList><ArticleId IdType="pubmed">26972993</ArticleId><ArticleId IdType="pmc">4879060</ArticleId><ArticleId IdType="doi">10.1016/j.semarthrit.2016.01.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Janwityanujit S, Totemchokchyakarn K, Verasertniyom O, Vanichapuntu M, Vatanasuk M (1995) Age-related differences on clinical and immunological manifestations of SLE. Asian Pac J Allergy Immunol 13(2):145&#x2013;149</Citation><ArticleIdList><ArticleId IdType="pubmed">8703243</ArticleId></ArticleIdList></Reference><Reference><Citation>Biazar C, Sigges J, Patsinakidis N, Ruland V, Amler S, Bonsmann G et al (2013) Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun Rev 12(3):444&#x2013;454</Citation><ArticleIdList><ArticleId IdType="pubmed">23000206</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2012.08.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Werth V (2002) Cutaneous lupus erythematosus: a review. Dermatol Clin 20(3):373&#x2013;85, v</Citation><ArticleIdList><ArticleId IdType="pubmed">12170873</ArticleId><ArticleId IdType="doi">10.1016/S0733-8635(02)00016-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebbe B, Orfanos CE (1997) Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 6(2):96&#x2013;104</Citation><ArticleIdList><ArticleId IdType="pubmed">9061657</ArticleId><ArticleId IdType="doi">10.1177/096120339700600204</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanprapaph K, Tankunakorn J, Suchonwanit P, Rutnin S (2021) Dermatologic manifestations, histologic features and disease progression among cutaneous lupus erythematosus subtypes: a prospective observational study in Asians. Dermatol Ther (Heidelb) 11(1):131&#x2013;147</Citation><ArticleIdList><ArticleId IdType="pubmed">33280074</ArticleId><ArticleId IdType="doi">10.1007/s13555-020-00471-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiewchengchol D, Murphy R, Edwards SW, Beresford MW (2015) Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature. Pediatr Rheumatol Online J 13:1</Citation><ArticleIdList><ArticleId IdType="pubmed">25587243</ArticleId><ArticleId IdType="pmc">4292833</ArticleId><ArticleId IdType="doi">10.1186/1546-0096-13-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomic-Lucic A, Petrovic R, Radak-Perovic M, Milovanovic D, Milovanovic J, Zivanovic S et al (2013) Late-onset systemic lupus erythematosus: clinical features, course, and prognosis. Clin Rheumatol 32(7):1053&#x2013;1058</Citation><ArticleIdList><ArticleId IdType="pubmed">23515605</ArticleId><ArticleId IdType="doi">10.1007/s10067-013-2238-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders CJ, Van Weelden H, Kazzaz GA, Sigurdsson V, Toonstra J, Bruijnzeel-Koomen CA (2003) Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 149(1):131&#x2013;137</Citation><ArticleIdList><ArticleId IdType="pubmed">12890206</ArticleId><ArticleId IdType="doi">10.1046/j.1365-2133.2003.05379.x</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>